Baxter International Inc. Declares Quarterly Dividend of $0.01 (NYSE:BAX)

Baxter International Inc. (NYSE:BAX) announced a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, August 28th will be paid a dividend of 0.01 per share by the medical instruments supplier on Thursday, October 1st. This represents a c) dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th.

Baxter International has decreased its dividend by an average of 0.1%per year over the last three years. Baxter International has a dividend payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Baxter International to earn $1.96 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Stock Up 7.6%

Shares of Baxter International stock opened at $26.65 on Friday. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00. The firm has a market capitalization of $13.76 billion, a PE ratio of -12.51, a price-to-earnings-growth ratio of 4.00 and a beta of 0.62. The company has a quick ratio of 1.23, a current ratio of 1.85 and a debt-to-equity ratio of 1.43. The stock’s fifty day moving average is $21.20 and its 200-day moving average is $19.56.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.80 billion. Baxter International had a positive return on equity of 16.15% and a negative net margin of 9.70%.Baxter International’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $0.59 EPS. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Equities analysts anticipate that Baxter International will post 1.91 earnings per share for the current year.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.